Tyra Biosciences Information
Contact top employees from
Tyra Biosciences
Summary
Tyra Biosciences is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO is occupied by Todd Harris. Its headquarters is located at Carlsbad, California, USA. The number of employees ranges from 1 to 25. The Tyra Biosciences annual revenue is estimated at < 1M. Total funding of the company - $50M. To connect with Tyra Biosciences employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
Biotechnology, oncology, Achondroplasia, FGFR biology, Structural drug design
SIC Code
2836
DMA Code
San Diego County
Founded
2018
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2015 | Public Company | 1 - 25 | 1.2M | $335.4M | |
| 2018 | Privately Held | 25 - 100 | 2.5M | $113.8M | |
| 2020 | - | 1 - 25 | < 1M | $50M | |
| 2019 | - | 10-50 | - | $- | |
| - | - | 1-10 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Length of Employment
Employee tenure at Tyra Biosciences shows a diverse range of experience levels:
7% have been with the company for less than 1 year36% for 1–2 years29% for 3–4 years21% for 5–7 years7% have over 11 years of service at Tyra BiosciencesEx-employees positions
In Company
In New Company
Contact top employees from
Tyra Biosciences
Maggie Wong
Senior Manager, Accounting and SEC Reporting
Corbin Occhino
Senior Scientist
Audrey Maylone
Manager CMC Operations
Marazban Sarkari
VP, Product Development and Technical Operations
Fernando Blanco
Asset Lead, Oncology Clinical Development & Medical Affairs
Tristen Asmann
Accounting Manager
Gary Price
Vice President of Quality
Judyth Zahora
Executive Director, QA
Sarah Honig
Senior Vice President, Corporate Development and Strategy
Stephanie Pierpoint
Senior Clinical Trial Manager
Erik Goluboff
Senior Vice President, Clinical Development
Melissa Gonzalez
Accounts Payable Specialist
Elisa Daley
Sr. Clinical Trial Associate
Cory Scott
Executive Director, Finance
Annette McAvoy
Sr. Director, Regulatory Affairs
Rafael Cassata
Senior Director Regulatory Affairs
S Michael Rothenberg
Member Board of Directors
Piyush Patel
Chief Development Officer
Zea Melton
Senior Manager Program Management
Alan Fuhrman
Chief Financial Officer
Julia Rueb
VP of Finance
Scott Drew
Sr. Director, Information Technology
Curt Dvorak
Senior Director of Medicinal Chemistry
Jacqueline Starrett
Senior Director
George Melko
Vice President, Regulatory Affairs
Matthew “Ross” Theriot
Director, Medical Affairs & Clinical Development, Skeletal Dysplasia
Isaac Blum
Director Global Supply Chain
Will Charlton MD
SVP, Clinical Development, Skeletal Dysplasia
Todd Harris
Founder & CEO
